FDA DEVICE FACTS
Novosyn Quick Absorbable Suture
Aesculap, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Novosyn Quick Absorbable Suture is indicated for use in general soft tissue approximation of the skin and mucosa, where only short term wound support (7-10 days) is required. Novosyn Quick suture is not intended for use in ligation in ophthalmic, cardiovascular or neurological procedures. TECHNOLOGICAL CHARACTERISTICS(compared to Predicate(s)) As established in this submission, the Novosyn Quick suture is a synthetic absorbable braided surgical suture offered undyed in the same range of diameters and cut lengths that are substantially equivalent to other predicate devices cleared by FDA. The subject device is shown to be substantially equivalent and has the same technological characteristics to its predicate devices through comparison in design, intended use, material composition, function and range of sizes. The device characteristics comparing the Novosyn Quick Absorbable Suture to the predicate devices are summarized below.
Aesculap, Inc. Novosyn Quick Absorbable Suture Primary Predicate Aesculap, Inc. Novosyn Absorbable Suture Ethicon, Inc. Vicryl Rapide Suture K# Pending K122734 K962480/K944110 Indications Novosyn Quick Absorbable Suture is indicated for use in general soft tissue approximation of the skin and mucosa, where only short term wound support (7-10 days) is required. Novosyn Quick suture is not intended for use in ligation in ophthalmic, cardiovascular or neurological procedures. Novosyn sutures are indicated for use in general soft tissue approximation and/or ligation, including use in ophthalmic procedures, but not for use in cardiovascular and neurological tissues. Vicryl Rapide suture is indicated only for use in superficial general soft tissue approximation of the skin and mucosa, where only short term wound support (7-10 days) is required. Vicryl rapide suture is not intended for use in ligation, ophthalmic, cardiovascular or neurological procedures. Absorption Type Short term absorbable Mid term absorbable Short term absorbable Absorption Essentially complete by4 2 days Essentially completed between 8-10 weeks Essentially complete by4 2 days Remaining Tensile Strength 5 days 50% 14 days 0% 2 weeks 75% (6-0 and larger) 2 weeks 56% (7-0 and smaller) 3 weeks 52% (6-0 and larger) 3 weeks 35 % (7-0 and smaller) 4 weeks 23 % (5-0 and larger) 5 days 50% 14 days 0% Material Polyglycolide-co-L-lactid 90/10 (PGLA) Polyglycolide-co-L-lactid 90/10 (PGLA) Polyglactin 910 (glycolic and lactic acid) Dyed, Un-dyed Un-dyed Un-dyed and Dyed Un-dyed Structure Braided Braided Braided Coating Polyglycolide-co-L-lactid 35/65 + Calcium Stearate Polyglycolide-co-L-lactid 35/65 + Calcium Stearate Caproloctone / Glycolide + Polyglactin 370 (glycolide/lactide) w/ Calcium Stearate Size 6-0 through 2 (various lengths) with or w/out needles attached 8-0 through 2 (various lengths) with or w/out needles attached 6-0 through 0 (various lengths) with or w/out needles attached Aesculap, Inc. Novosyn Quick Absorbable Suture Primary Predicate Aesculap, Inc. Novosyn Absorbable Suture Ethicon, Inc. Vicryl Rapide Suture K# Pending K122734 K962480/K944110 Thread length -45 cm to 150 cm -ligature reels of longer length -5 cm to 150 cm -ligature reels of longer length -45cm to 135cm Physical:
- Diameter
- Length
- Needle Attachment
- Tensile Strength
All characteristics meet USP Requirements, except for diameter. All characteristics meet USP Requirements, except for diameter. All characteristics meet USP Requirements, except for diameter. Needle material 300 stainless steel 300 stainless steel unknown Packaging Foil packaging in a second outer peel-pack with paper and plastic film Foil packaging in a second outer peel-pack with paper and plastic film unknown Sterilization Gamma irradiation Ethylene Oxide (EO) Ethylene Oxide (EO) or Gamma Irradiation
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。